T1	Participants 53 93	patients with advanced renal cell cancer
T2	Participants 319 380	pre-treated patients with advanced renal cell carcinoma (RCC)
T3	Participants 754 808	Of the 416 patients, 362 were included in the analysis
T4	Participants 1441 1479	pre-treated patients with advanced RCC
